Discover the Cipla Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

Welcome to the Cipla Stock Liveblog, your go-to platform for real-time updates and analysis on a top-performing stock. Stay ...

The shares of the third largest pharmaceutical firm Cipla rose 2.44 per cent at Rs 1,454.20 a piece on the BSE intraday after ...

Cipla, one of India's largest drugmakers by sales, reported a bigger-than-expected third-quarter profit on Tuesday helped by ...

Cipla's oncology drug Abraxane will be launched from its Goa facility while respiratory drug Advair will be rolled out from ...

Mumbai: Cipla has announced that the Company will invest approx. ZAR 900 million in equity share capital of Cipla Medpro ...

The company reported a 48% year-on-year (y-o-y) jump in its consolidated net profit to ₹1,571 crore in October-December, ...

Cipla Ltd is set to invest ZAR 900 million in its wholly-owned subsidiary, Cipla Medpro South Africa Proprietary Ltd. The ...

Cipla , one of India's largest drugmaker by sales, reported a bigger-than-expected third-quarter profit on Tuesday, helped by ...

CMSA, is a wholly owned subsidiary of Cipla, and is the holding company for the group operations in South Africa. The group is involved in the manufacturing, marketing, and supply of pharmaceutical ...

The reported net profit is higher with the Rs 1,225 crore average net profit estimated by 10 brokerages polled by ...

Motilal Oswal retains Neutral on Cipla; see limited upside due to delayed niche product approvals. Learn more about the ...